Publications by authors named "L Venat"

Claim this Profile
[
[THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists].
Marion Boucheteil, Sophie Leobon, Kim-Arthur Baffert, Soline Huet, Tiffany Darbas, Laurence Venat

Bull Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial.
Henri Azaïs, Camille Brochard, Valérie Taly, Louise Benoit, Gwenaël Ferron, Laurence Venat

Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up.
A Dezellus, S Mirallie, F Leperlier, B Sauterey, P-E Bouet, L Venat

Breast· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
Aurélie Moniot, Christophe Schneider, Laure Chardin, Elisa Yaniz-Galende, Catherine Genestie, Laurence Venat

Mol Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.
Isabelle L Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, Laurence Venat

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis